Related Experiment Video
Updated: Aug 16, 2026

Real-time X-ray Imaging of Lung Fluid Volumes in Neonatal Mouse Lung
Published on: July 18, 2016
Changes in body water compartments with diuretic therapy in infants with chronic lung disease
Insights
Diuretic therapy in preterm infants with chronic lung disease reduced extracellular water. Combination therapy with furosemide and metolazone increased urine output more effectively.
Area of Science:
- Neonatal Medicine
- Pediatric Nephrology
- Respiratory Medicine
Background:
- Chronic lung disease is common in preterm infants.
- Fluid management is critical in these vulnerable infants.
- Diuretics are often used to manage fluid overload.
Purpose of the Study:
- To investigate the effects of diuretic therapy on body water compartments in preterm infants with chronic lung disease.
- To compare the efficacy of furosemide alone versus furosemide plus metolazone.
Main Methods:
- Randomized study of preterm infants (24-28 weeks gestational age) with chronic lung disease.
- Infants received either furosemide alone or furosemide plus metolazone for 4 days.
- Body water compartments, including extracellular water (ECW) and plasma volume (PV), were assessed.
Main Results:
- Both treatment groups showed a significant decrease in ECW (P < 0.05) without changes in PV, total body water, or body weight.
- The reduction in ECW was similar between the furosemide-only and combination therapy groups.
- Combination therapy with furosemide and metolazone significantly increased urine output compared to furosemide alone.
Conclusions:
- Diuretic therapy in preterm infants with chronic lung disease causes intercompartmental shifts in body water, reducing interstitial water while preserving plasma volume.
- Combination therapy with furosemide and metolazone is more effective in inducing diuresis than furosemide alone.
Abstract:
The effects of diuretic therapy on body water compartments were studied in preterm infants with chronic lung disease. Gestational age of the infants ranged from 24 to 28 weeks, while the median postnatal age at the time of study was 40 days. Infants were randomized to receive furosemide (1.0 mg/kg/day) alone (n = 5) or combined with metolazone (0.2 mg/kg/day, n = 7) for 4 consecutive days. Treatment in both groups produced a significant decrease (P < 0.05) in extracellular water (ECW) without changes in plasma volume, total body water or body weight. The decrease in ECW with furosemide (503 +/- 28 to 446 +/- 19 ml/kg initial body weight) was of similar magnitude to that seen with combined furosemide plus metolazone (522 +/- 30 to 454 +/- 15 ml/kg initial body weight). Water and electrolyte intakes were similar in both groups and unchanged over the course of the study. These findings suggest that in infants with chronic lung disease, diuretic therapy induces intercompartmental shifts in body water, ultimately decreasing interstitial water while preserving PV. Only combined treatment with furosemide plus metolazone produced a significant increase in urine output, confirming the increased efficacy of combination therapy in inducing diuresis.
More Related Videos
Related Concept Videos
Antihypertensive Drugs: Action of Diuretics
Formation of Dilute Urine
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
Disorder of Water Balance
Dehydration
Dehydration occurs when the body loses fluids (particularly water).
Causes:
The major causes of dehydration include excessive sweating, fever, vomiting, diarrhea, and diuresis.
Signs and Symptoms:
Symptoms primarily include intense...
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion

